Zydus Lifesciences Share Buyback: Zydus Lifesciences, a company operating in the pharma sector is buying shares worth ₹ 600 crore by paying a 20% premium price. Zydus Lifesciences has made a big announcement of share buyback at a price of ₹ 1009 per share.
The best news has arrived for the investors of Zydus Lifesciences Pharma Company. Zydus Lifesciences made a big announcement for its shareholders. Zydus Lifesciences’ results for the third quarter of 2024 have come and the company has planned to do a share buyback.
Zydus will do the buyback through the tender route. As soon as this news came, there was a rise in the company’s shares. The company will spend a total of ₹600 crore on share buyback. Zydus Lifesciences has announced to give a share buyback price to the shareholders at a 20% premium price i.e. ₹ 1009 per share.
Read More: Nvidia Just Miss to surpassing Amazon’s market value after AI boost
Zydus Lifesciences has recently released its third quarter results in which the company has seen a good year-on-year improvement and the profit margin has also seen improvement. There has also been a boost in the consolidated profit and consolidated income of the company. On this basis, the company wants to buy back your shares.
Zydus Lifesciences Financial Results
Zydus Lifesciences’s EBITDA has shown a growth of 15.27%. The EBITDA of the company for the December quarter was ₹ 956 crore, and it has increased to ₹ 1102 crore. Zydus Lifesciences has seen a growth of 26.8% in year-on-year profits. The consolidated profit of the company was ₹ 623 crore, which increased to ₹ 790 crore in the December quarter.
Read More: After LIC in PSU Stocks, SBI market cap crosses ₹ 6 lakh crore
The consolidated income of Zydus Lifesciences was ₹ 4257 crore before the December quarter, which has crossed ₹ 4505 crore with a growth of 5.8%. The share price of Zydus Lifesciences has increased by 11% in the last 1 month and by 65% in the last 1 year to ₹804. That is why now the company will buy back shares at the price of ₹ 1009 per share, that is, investors will get a 20% premium price.
So, have you invested in Zydus Lifesciences before or not? Do tell us in the comments.